Structure

InChI Key LVXJQMNHJWSHET-AATRIKPKSA-N
Smile COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1
InChI
InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H25ClFN5O2
Molecular Weight 469.95
AlogP 5.16
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 7.0
Polar Surface Area 79.38
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 33.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Epidermal growth factor receptor erbB1 inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase EGFR family
- 46 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

MCS

Scaffolds

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Respiratory, thoracic and mediastinal disorders
17.11
Cardiac disorders
15.79
Gastrointestinal disorders
14.47
Hepatobiliary disorders
10.53
General disorders and administration site conditions
9.21
Infections and infestations
5.26
Psychiatric disorders
5.26
Renal and urinary disorders
5.26
Vascular disorders
5.26
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.95
Injury, poisoning and procedural complications
2.63
Nervous system disorders
2.63
Skin and subcutaneous tissue disorders
2.63

Cross References

Resources Reference
CAS NUMBER 1110813-31-4
ChEMBL CHEMBL2105719
EPA CompTox DTXSID80146359
FDA SRS 5092U85G58
Guide to Pharmacology 7422
PDB 1C9
PubChem 11511120
SureChEMBL SCHEMBL25637
CAS NUMBER 1110813-31-4
ChEBI 132268
ChEMBL CHEMBL2110732
DrugBank DB11963
DrugCentral 5297
EPA CompTox DTXSID50149493
FDA SRS 5092U85G58
Guide to Pharmacology 7422
PDB 1C9
PubChem 11511120
SureChEMBL SCHEMBL25637
ZINC ZINC000072266312